Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT05312853 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Evaluating the Diagnostic and Predictive Value of Non-invasive Tests (NITs) on the Progression of Chronic Liver Disease.

Study acronym: NITOutcomes
StatusNot Yet Recruiting
PhaseNot specified
Started
View on ClinicalTrials.gov ↗

Record History

See every version on ClinicalTrials.gov ↗

  1. Primary completion date: Apr 15, 2032 to Apr 15, 2034v2 Show 4 more changesShow less
    • Start date: Apr 15, 2022 to Jan 15, 2024
    • Primary endpoint revised
    • Study completion date: Dec 31, 2032 to Dec 31, 2034
    • Secondary endpoint revised
  2. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
Primary objective is to study the relevance of non-invasive test (NITs) in predicting disease stage (diagnostic biomarker) and outcome (predictive biomarker) in patients with suspected or established liver disease and cirrhosis.
Trial Details
NCT Number NCT05312853
Lead Sponsor Johannes Gutenberg University Mainz
Collaborators: Boehringer Ingelheim, Nordic Bioscience A/S
Conditions
(from sponsor)		 Chronic Liver Disease
Enrollment 250 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov